Primary study · included by 1 review

The dental safety profile of high-dose radioiodine therapy for thyroid cancer: long-term results of a longitudinal cohort study.

Walter 2007 · Walter Martin A, Turtschi Christian P, Schindler Christian, et al. · Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2007

Included by

Salivary and lacrimal disorders in patients treated with radioiodine for differentiated thyroid cancer.

Non-Cochrane · prognostic · 2026 · cited as Walter 2007 · Supplementary Table S3 (included studies); Figs. 1-3

Outcome this study informs	Pooled effect	Evidence	Certainty
Sialadenitis (pooled prevalence) Radioiodine (I131) therapy · more than 1 year after RIT	Prevalence 0.24 [0.21, 0.29]	3 studies · 405 participants	GRADE not reported

1 including review in total.